Home › Targets › FLT3

FLT3 (4 companies · 5 programs)

Companies with an active program directed at FLT3.

Cullinan Therapeutics, Inc. CGEM

CLN-049 — Acute Myeloid Leukemia Phase 1
CLN-049 — Myelodysplastic Syndrome Phase 1

Allogene Therapeutics, Inc. ALLO

ALLO-819 — Acute Myeloid Leukemia

Biomea Fusion, Inc. BMEA

BMF-500 Phase 1

Kura Oncology, Inc. KURA

KOMZIFTI — Acute Myeloid Leukemia Phase 1